WallStreetZenWallStreetZen

NASDAQ: RYTM
Rhythm Pharmaceuticals Inc Stock Ownership - Who owns Rhythm Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Rhythm Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph ShulmanChief Technical Officer2025-10-1612,344$30.66
$378.47kBuy
Joseph ShulmanChief Technical Officer2025-10-162,093$27.35
$57.24kBuy
Joseph ShulmanChief Technical Officer2025-10-163,412$112.81
$384.91kSell
Joseph ShulmanChief Technical Officer2025-10-162,693$110.95
$298.78kSell
Joseph ShulmanChief Technical Officer2025-10-168,332$112.06
$933.64kSell
Joseph ShulmanChief Technical Officer2025-09-0216,781$105.30
$1.77MSell
Joseph ShulmanChief Technical Officer2025-09-0214,687$30.66
$450.30kBuy
Joseph ShulmanChief Technical Officer2025-09-022,094$27.35
$57.27kBuy
Joseph ShulmanChief Technical Officer2025-08-214,188$100.07
$419.09kSell
Joseph ShulmanChief Technical Officer2025-08-214,188$27.35
$114.54kBuy

1 of 12

RYTM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RYTM insiders and whales buy or sell their stock.

RYTM Shareholders

What type of owners hold Rhythm Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.44%6,267,538$711.11MInstitution
Baker Bros Advisors LP8.44%5,604,483$635.88MInstitution
Ra Capital Management LP8.37%5,561,359$630.99MInstitution
Primecap Management Co7.34%4,878,037$553.46MInstitution
Ra Capital Management LP6.57%4,360,860$494.78MInsider
Vanguard Group Inc5.40%3,589,114$407.22MInstitution
Nea Management Company LLC4.38%2,909,956$330.16MInstitution
Orbimed Advisors LLC4.14%2,750,079$312.02MInsider
Perceptive Advisors LLC3.64%2,418,299$274.38MInstitution
Fmr LLC2.94%1,953,441$221.64MInstitution

1 of 3

RYTM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RYTM87.82%12.18%Net SellingNet Buying
CORT28.93%71.07%Net SellingNet Selling
HALO77.24%22.76%Net SellingNet Selling
NUVL75.12%24.88%Net SellingNet Selling
CYTK90.09%9.91%Net SellingNet Selling
View Top Biotech Stocks

Rhythm Pharmaceuticals Stock Ownership FAQ

Who owns Rhythm Pharmaceuticals?

Rhythm Pharmaceuticals (NASDAQ: RYTM) is owned by 100.19% institutional shareholders, 13.89% Rhythm Pharmaceuticals insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Rhythm Pharmaceuticals shareholder, owning 4.36M shares representing 6.57% of the company. Ra Capital Management LP's Rhythm Pharmaceuticals shares are currently valued at $496.66M.

If you're new to stock investing, here's how to buy Rhythm Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.